Juxtapid
These highlights do not include all the information needed to use JUXTAPID safely and effectively. See full prescribing information for JUXTAPID. JUXTAPID (lomitapide) capsules, for oral use Initial U.S. Approval: 2012
e4c45bb5-15f4-437e-ab98-a649b3676d14
HUMAN PRESCRIPTION DRUG LABEL
Apr 28, 2022
Amryt Pharmaceuticals DAC
DUNS: 985632604
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
lomitapide mesylate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (1)
lomitapide mesylate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (1)
lomitapide mesylate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (1)
lomitapide mesylate
Product Details
FDA regulatory identification and product classification information